Vestiage Announces Award of Three Major Exclusive Territories to Beacon Health

Share Article

Vestiage, a leading anti-aging lifestyle company specializing in revolutionary science-based anti-aging skin care and supplements, announced today that it has awarded the key territories of Boston, New York City, and Miami/Palm Beach to Beacon Health of Boston for the sale of Reluma Skin Illuminating Facial Care to select spas, salons, physicians, skin care boutiques and retailers effective immediately. More information on Reluma is available at

Reluma is the latest science in facial care and is no doubt the future of the industry - Scott Kimball, CEO, Vestiage

Vestiage, Inc. (stock symbol "VEST") a publicly traded anti-aging lifestyle company focused on science-based research and development, sales and marketing of premium branded highly effective anti-aging cosmeceuticals and nutraceuticals, announced today that it has awarded the exclusive Vestiage territories of Boston, New York City, and Miami/Palm Beach to Beacon Health of Boston. Beacon Health will begin selling the Reluma brand to select premium and prestige salons, spas, resorts, physicians, skin care boutiques and select retailers immediately, Reluma is a revolutionary facial care product using the latest human stem cell technology. Reluma is manufactured in the Reluma Laboratory in California, USA.

"I have known the owners of Beacon Health for over 30 years," said Scott Kimball, CEO of Vestiage, Inc. "These territories are significant and I am pleased to have Beacon handling them and building distribution for our Reluma brand throughout each of them."

The three territories are estimated to cover more than 10,000 potential customers and generate more than $40 million in wholesale revenue to Vestiage.    

The Vestiage Territory Program awards exclusive Vestiage Metropolitan Statistical Areas ("MSA's") to qualified companies or individuals that sell to salons, spas, retailers, resorts and physicians in each MSA territory. Vestiage provides product literature, retail displays, product training, and marketing/sales support.

Vestiage gives its territory awardees the ability to sell the most sophisticated and advanced skin care line with very little investment. Vestiage is not charging for the territories. Vestiage pays for all the product that is sold in each territory so the territory awardees never have to come out of pocket and buy product or deliver product to customers. Vestiage provides marketing materials, retail displays, and pays for the product that is ordered, ships to the buyers, and pays the territory awardees a commission on all sales in the territory. Vestiage further supports the salon or spa customer with a media and PR campaign that highlights their business in the press designed to drive premium and prestige customers to their locations.

The complete Reluma skin care line sells for $435 at retail. According to certain industry experts at Canyon Ranch, the average woman at their spa locations spends an average of $750 per month on product. This does not include facials or other procedures. The Reluma skin care regimen is simple and includes a cleanser, a serum, a moisturizer, and an eye cream. A minimum wholesale order for a typical premium salon or spa customer is 12 of each of the four facial care products. Commissions are paid to the terrritory awardee on the wholesale amounts sold. More information is available upon request to qualified applicants.

"The Reluma line is attractive to the higher rated salons and spas because it utilizes the latest science, the clientele love how it feels and works, and financially the salon or spa can make a large amount of money simply by carrying the line, using it in 'stem cell facials' and putting as few as 2 women a day onto the Reluma regimen" said Kimball.

Several attractive territories remain available including Dallas, San Francisco, and Southern California. For more information on the Vestiage Exclusive Territory Program, please email your request to info(at)vestiageinc(dot)com or call 949-258-4404 and ask for Garrett Heiser, Vice President of Operations.

About Vestiage, Inc.

Vestiage (stock symbol "VEST") is a publicly traded anti-aging lifestyle company offering premium branded science-based cosmeceuticals and nutraceuticals. Vestiage is focused on the use of human stem cell, marine/ocean, and cutting edge botanically based science and ingredients to produce highly potent, elegantly formulated, effective products with clinically proven ingredients. Using high potency and novel ingredient combinations, Vestiage creates and distributes cosmeceuticals such as Reluma ( and multifunctional nutraceuticals through Monterey Bay Nutraceuticals ( Vestiage brands address the top “in demand” anti-aging consumer concerns. Vestiage research is focused on longevity and human performance science that covers both the cognitive and physical realms. As clinical results validate discoveries, Vestiage intends to apply new potential ingredients or ingredient formulations and combinations to its anti-aging products across brands. To learn more, visit the Company website,

About Beacon Health

Beacon Health of Boston distributes the most advanced science-based health and wellness oriented products available. For more information on opportunities with Beacon Health, call 617.833.0464.

This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forwardlooking statements can be identified by the use of terms such as "believe," "expects," "plan," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause industry trends or our actual results to be materially different from any future results expressed or implied by these statements. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to: (i) changes in or new government regulations or increased enforcement of the same, (ii) unavailability of desirable acquisitions or inability to complete them, (iii) increased costs, including from increased raw material or energy prices, (iv) changes in general worldwide economic or political conditions, (v) adverse publicity or negative consumer perception regarding nutritional supplements, anti-aging or stem cell facial care products or stem cell technology in general, (vi) issues with obtaining raw materials of adequate quality or quantity, (vii) litigation and claims, including product liability, intellectual property and other types, (viii) disruptions from or following acquisitions including the loss of customers, (ix) increased competition, (x) slow or negative growth in the anti-aging or cosmetics, beauty, or nutritional supplement industry or the healthy foods or anti-aging channel, (xi) the loss of key personnel or the inability to manage our operations efficiently, (xii) problems with information management systems, manufacturing efficiencies and operations, (xiii) insurance coverage issues, (xiv) the volatility of the stock market generally and of our stock specifically, (xv) increases in the cost of borrowings or unavailability of additional debt or equity capital, or both, or fluctuations in foreign currencies, and (xvi) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest and other factors outside of our control. Copies of our SEC reports are available upon request from our investor relations department or may be obtained at

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Garrett Heiser
Follow us on
Visit website